NRG1 and head and neck squamous cell carcinoma: To investigate the clinical significance of the HER3 pathway in SCCHN, we first evaluated the expression status of HER3 and its ligand NRG1 in 100 cases of OSCC, which is the 4th leading cancer type in the male population in Taiwan, through immunohistochemical staining.